The Influence of EMG-triggered Robotic Movement on Function and Mobility of Stroke Patients

NCT ID: NCT04497545

Last Updated: 2020-08-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

71 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-02-24

Study Completion Date

2020-01-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Rehabilitation of lower limbs after a stroke supported by robots aims to return to independence and minimize disability caused by the incident, but the results have been mixed. Objective of the study was to assess the changes in gait capabilities, muscle tone and daily activities in patients after a recent stroke who underwent a 6-week supervised rehabilitation process using exercises on the LUNA EMG neurorehabilitation robot. A total of 60 participants with impaired motor function and gait after subacute stroke were included in the study. Each patient was randomly assigned to an intervention (robot) or control group (RG or CG). All patients, except standard therapy, underwent 1 session of therapy per day, 5 days a week for 6 weeks. People with RG had 30 minutes of training sessions on the Luna EMG robot, while CG received exercises on the lower limb rotor. Patients were evaluated before the start of the study, and then after 2, 4 and 6 weeks of therapy using the Ashworth scale, Rivermead mobility index (RMI), Repty functional index, Time Up and Go test (TUG) and muscle circumference on the thigh.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ischemic Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Study Group

A four-week rehabilitation program (Monday to Friday) involving the hour of individual therapy and 30 minutes of therapy on the Luna EMG device.

Group Type EXPERIMENTAL

Luna EMG

Intervention Type DEVICE

The duration of the overall therapeutic intervention in both groups will be the same.

Control Group

A four-week rehabilitation program (Monday to Friday) involving one hour of individual therapy and 30 minutes on lower limb rotor

Group Type OTHER

lower limb rotor

Intervention Type DEVICE

The duration of the overall therapeutic intervention in both groups will be the same.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Luna EMG

The duration of the overall therapeutic intervention in both groups will be the same.

Intervention Type DEVICE

lower limb rotor

The duration of the overall therapeutic intervention in both groups will be the same.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ischemic stroke,
* not later than 6 months ago,
* muscle strength of extensors and knee flexors on the Lovetta scale below 3,
* functional disorders of the lower limb,
* patient's condition allowing full understanding of commands
* continued/uninterrupted rehabilitation process for 28 days

Exclusion Criteria

* cognitive impairment-lack of or poor cooperation between the patient and the therapist,
* stroke (more than 6 months after the incident),
* unstable clinical condition,
* muscle strength of knee extensors and flexors on the Lovett scale greater than or equal to 3,
* rigid fixed contractures within the lower limb,
* significant spasticity (Ashworth scale of 3 and above)
Minimum Eligible Age

29 Years

Maximum Eligible Age

91 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

EGZOTech

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rehstab

Limanowa, Malopolskie Voivodship, Poland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Poland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Limanowa Trial

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.